Ilya Golubovich is the founding partner of I2BF Global Ventures.Ilya Golubovich is the Founding Partner of I2BF Global Ventures, one of the leading venture funds facilitating the advancement of the second wave of digital transformation, headquartered in New York City. Ilya serves as a Director on the Boards of ServiceTitan, Presto, Octi and many others; his investment portfolio includes companies in vertical SaaS, deep tech, and new media. Ilya is a member of the Advisory Council of the Physics and Astronomy Department of Johns Hopkins University. He holds a Management Science and Engineering degree from Stanford University.
Alexander is a Partner and the Head of the Moscow office.Alex joined I2BF in 2007 and currently oversees the firm’s technology initiative with a focus on SaaS, Robotics and Autonomous Driving solutions. Alexander is a member of the Board of Directors at RoboCV, Titan Power Solution, and Buzzoola. He is also a mentor at the Alchemist Accelerator. Prior to joining I2BF, he worked at Citigroup, where he held positions in finance and risk management. Alexander holds a degree with distinction in Mathematics from Lomonosov Moscow State University.
Mike is a Senior Partner, Head of the New York office, and serves as General Counsel.Mike leads the firm’s digital initiative, with a focus on media, SaaS, the Internet of Things and commercial platforms. Mike is on the Board of StrongArm Technologies. Prior to joining I2BF Mike was with Wilson Sonsini Goodrich & Rosati P.C., a leading Silicon Valley law firm. Mike holds a J.D. from the University of California at Berkeley School of Law and a B.A. in Business Administration in Management Information Systems from the University of Texas at Austin.
Greg joined I2BF in 2013. He enjoys operational challenges of scale-ups and turnarounds, and is passionate about emerging technologies in energy, infrastructure, finance, and healthcare. Greg curates the Digital Healthcare portfolio and serves on the Advisory Board of Inbox Health. Greg's Digital Health investments include Agathos, CircleLink Health, Inbox Health and Wellth. Prior to I2BF, Greg worked for Stroud Consulting, a boutique Industrial Operations & Management consultancy, and interned at Lux Research (a research company founded by Lux Capital), where he performed strategic analysis and market research in bio-based chemicals, bio-fuels, and bio-materials. Greg graduated summa cum laude from Columbia University with a major in Biomedical Engineering, and a minor in Chemical Engineering, his undergraduate organic chemistry research contribution was recognized in a publication in Chemical Communications (Royal Society of Chemistry) in July 2012.